Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #34 on Assembly Biosciences Inc (ASMB)
DewDiligence
05/06/21 5:41 PM
#35 RE: DewDiligence #34
Cash, cash equivalents and marketable securities were $214.9 million as of March 31, 2021, compared to $216.4 million as of December 31, 2020. This result includes $34.1 million of net proceeds from the issuance of common shares under Assembly Bio’s at-the-market (ATM) program.
09/01/21 4:20 PM
#36 RE: DewDiligence #34